OrthoPediatrics (NASDAQ:KIDS) Lowered to “Sell” Rating by Wall Street Zen

OrthoPediatrics (NASDAQ:KIDS) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Other research analysts have also issued reports about the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OrthoPediatrics in a research report on Thursday, January 22nd. BTIG Research restated a “buy” rating and issued a $23.00 price objective on shares of OrthoPediatrics in a report on Wednesday, October 29th. TD Cowen raised shares of OrthoPediatrics to a “strong-buy” rating in a research report on Tuesday, January 27th. Canaccord Genuity Group assumed coverage on shares of OrthoPediatrics in a research note on Wednesday, December 10th. They issued a “buy” rating and a $24.00 target price for the company. Finally, Needham & Company LLC decreased their target price on shares of OrthoPediatrics from $42.00 to $26.00 and set a “buy” rating for the company in a research report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $23.89.

OrthoPediatrics Trading Down 0.5%

NASDAQ KIDS opened at $16.96 on Friday. The company has a current ratio of 7.40, a quick ratio of 3.52 and a debt-to-equity ratio of 0.28. OrthoPediatrics has a 1-year low of $15.28 and a 1-year high of $26.40. The firm’s fifty day simple moving average is $17.67 and its 200-day simple moving average is $18.21. The company has a market capitalization of $425.36 million, a PE ratio of -8.70 and a beta of 1.12.

Hedge Funds Weigh In On OrthoPediatrics

A number of institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. boosted its holdings in shares of OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after buying an additional 1,139 shares during the period. Northwestern Mutual Wealth Management Co. raised its holdings in OrthoPediatrics by 5,226.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock worth $46,000 after acquiring an additional 2,561 shares during the period. Caption Management LLC acquired a new position in OrthoPediatrics during the 3rd quarter worth $54,000. BNP Paribas Financial Markets boosted its holdings in OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock valued at $61,000 after acquiring an additional 1,235 shares during the period. Finally, State of Wyoming boosted its holdings in OrthoPediatrics by 189.7% during the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock valued at $121,000 after acquiring an additional 4,467 shares during the period. Institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.